Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in metformin utilisation and dose appropriateness in Australia.
Moon J, Kumar SS, Graham GG, Baysari MT, Williams KM, Chen W, Viardot A, Greenfield JR, Day RO. Moon J, et al. Among authors: kumar ss. Eur J Clin Pharmacol. 2016 Dec;72(12):1489-1496. doi: 10.1007/s00228-016-2117-y. Epub 2016 Aug 27. Eur J Clin Pharmacol. 2016. PMID: 27568311
Metformin therapy in patients with chronic kidney disease.
Duong JK, Roberts DM, Furlong TJ, Kumar SS, Greenfield JR, Kirkpatrick CM, Graham GG, Williams KM, Day RO. Duong JK, et al. Among authors: kumar ss. Diabetes Obes Metab. 2012 Oct;14(10):963-5. doi: 10.1111/j.1463-1326.2012.01617.x. Epub 2012 May 27. Diabetes Obes Metab. 2012. PMID: 22564555
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
Duong JK, Kumar SS, Kirkpatrick CM, Greenup LC, Arora M, Lee TC, Timmins P, Graham GG, Furlong TJ, Greenfield JR, Williams KM, Day RO. Duong JK, et al. Among authors: kumar ss. Clin Pharmacokinet. 2013 May;52(5):373-84. doi: 10.1007/s40262-013-0046-9. Clin Pharmacokinet. 2013. PMID: 23475568 Clinical Trial.
Could metformin be used in patients with advanced chronic kidney disease?
Kumar SS, Graham GG, Smith FC, Furlong TJ, Greenfield JR, Stocker SS, Carland JE, Day RO. Kumar SS, et al. Diabetes Obes Metab. 2017 Feb;19(2):302-303. doi: 10.1111/dom.12806. Epub 2016 Nov 9. Diabetes Obes Metab. 2017. PMID: 27735109 No abstract available.
Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration.
Smith FC, Kumar SS, Furlong TJ, Gangaram SV, Greenfield JR, Stocker SL, Graham GG, Williams KM, Day RO. Smith FC, et al. Among authors: kumar ss. Am J Kidney Dis. 2016 Dec;68(6):990-992. doi: 10.1053/j.ajkd.2016.08.017. Epub 2016 Oct 15. Am J Kidney Dis. 2016. PMID: 27751611 No abstract available.
Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).
Kumar SS, McManus H, Radovich T, Greenfield JR, Viardot A, Williams KM, Cronin P, Day RO. Kumar SS, et al. Eur J Clin Pharmacol. 2018 Oct;74(10):1327-1332. doi: 10.1007/s00228-018-2506-5. Epub 2018 Jun 24. Eur J Clin Pharmacol. 2018. PMID: 29938343
718 results